Anemia and Hepatitis C Treatment
Jan 24, 2012
1 Comment
In opposition to what seems logical, research demonstrates that becoming anemic while on Hepatitis C therapy is not such a bad thing.
Continue reading »Archives
Bristol-Myers Gains Momentum with All-Oral Hep C Therapy
In a recent study, over one third of previous non-responders cleared Hepatitis C with an interferon-free combo of two Bristol-Myers experimental drugs.
Continue reading »Hepatitis C Gains Access to Brain Cells
Helping to explain why Hepatitis C can cause extrahepatic manifestations (problems outside of the liver), American researchers confirmed that certain brain cells are susceptible to the Hepatitis C virus.
Continue reading »Liver Cancer More Likely with Hep C and Fatty Liver
Two separate Mayo Clinic studies find that liver cancer rates are magnified by obesity and Hepatitis C infection.
Continue reading »Novel Hep C Vaccine in Phase 1 Trial
By targeting the inside of a Hepatitis C viral cell for a greater T-cell response, Oxford researchers are one step closer to a vaccine for preventing Hepatitis C infection.
Continue reading »Fast-Track Given to Hepatitis C Drug ACH-1625
Jan 9, 2012
1 Comment
Likely due to its convenient dosing, safety and tolerability, Achillion's ACH-1625 has been awarded fast-track status by FDA.
Continue reading »CE Mark Granted to Roche's New Hep C Tests
Indicative of its compliance with Europe's standards, Roche's tests to confirm Hepatitis C infection and predict treatment response have been acknowledged by the EU.
Continue reading »MicroRNA Molecule Significant in Hep C Infection and Treatment
New research demonstrates how Hepatitis C hijacks a specific, microRNA molecule. The study clarifies why an experimental antiviral drug that binds to this microRNA molecule effectively targets the Hepatitis C virus.
Continue reading »An Overview of Autoimmune Hepatitis
Jan 3, 2012
1 Comment
Find out about the prevalence, signs and symptoms and treatment for autoimmune hepatitis.
Continue reading »
